Popular in Life Sciences


Direct Fit to Nature

The Antidepressant Effects of Lactate

Genetic Approaches to Develop Salt Tolerant Germplasm

A roadmap for collection, handling and storage of blood extracellular vesicles

The search for ‘evolution-proof’ antibiotics

Blood Biomarkers in the Diagnosis of Alzheimer’s Disease

Embed Cite Participate

Oligomeric forms of the peptide, β-amyloid, (Aβ) are known to be toxic to human and rodent neurones, and have been identified as possible causative agents in the loss of cognitive function in Alzheimer’s Disease (AD). An ELISA assay has been developed capable of detecting oligomeric forms of Aβ in biological fluids, but not detecting monomeric species. The ELISA has been validated with a number of synthetic variant sequences of Aβ and the effects of known inhibitors of Aβ oligomer formation. Significantly raised levels of oligomers were detected in sera samples from AD patients, compared to age-matched control sera.

Publication

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
Log-in or Sign-up to Faculti
Currently viewing as guest. You have insight(s) remaining for this month.
Copyright © Faculti Media Limited 2023. All rights reserved.
Recommend Faculti to your librarian

error: